Procept BioRobotics (Nasdaq: PRCT) is facing scrutiny following a report from short seller Spruce Point Capital Management. The investment firm, which is known for its short-selling strategies, challenged the surgical robotics company’s claims of market dominance and raised concerns about its growth projects, product adoption hurdles, and the safety of its Aquablation system. Spruce Point […]
Procept BioRobotics
Procept Biorobotics wins FDA nod to study surgical robot for treating prostate cancer
Procept BioRobotics (Nasdaq:PRCT) announced today that the FDA approved an investigational device exemption (IDE) trial for its Aquablation therapy. The WATER IV PCa trial will compare Aquablation to radical prostatectomy. Procept expects the study to enroll up to 280 men with Grade Group 1 to 3 localized prostate cancer. It takes place across 50 centers, […]
The top 10 urology device stories of 2024 so far
Urology Week 2024, which closes out The Urology Foundation’s Urology Awareness Month, is a good time to highlight the innovations in this space. This week (Sept. 23-29), is an initiative of the European Association of Urology that brings together national urological societies, urology practitioners, urology nurses, patients and their families, and politicians to create awareness of urological […]
FDA clears next-gen surgical robot from Procept Biorobotics
Procept BioRobotics (Nasdaq:PRCT) announced today that it received FDA 510(k) clearance for its next-generation Hydros robotic surgery system. Hydros delivers the San Jose, California-based company’s Aquablation therapy. The company received FDA investigational device exemption (IDE) for its Aquablation procedure in September 2023. Aquablation uses waterjet resection to precisely eradicate prostate tissue. It provides the potential […]
Procept BioRobotics wins FDA IDE for Aquablation prostate cancer therapy
Procept BioRobotics (Nasdaq:PRCT) announced today that it received FDA investigational device exemption (IDE) for its Aquablation therapy. The IDE allows Procept to initiate a single-arm feasibility study for the Aquablation prostate cancer therapy in the U.S. Data generated from the study could support future research and regulatory applications in the U.S. The company plans to […]
Procept Biorobotics taps industry veteran as new CEO
Procept BioRobotics recently announced that Reza Zadno, former CEO of ophthalmology tech company Avedro, has taken over the corner office at Procept. Zadno has more than three decades of leadership in the medical device industry, with a track record of successfully leading young companies to acquisitions. The latest was Avedro, which Glaukos (NYSE:GKOS) acquired for an […]
Medicare might cover more cutting-edge medtech and pay more for it, too
The Centers for Medicare and Medicaid Services (CMS) said today it wants to give Medicare patients better access to cutting-edge medical devices, and that it’s willing to pay more for them beginning in fiscal year 2020. In its proposed rule, CMS said it might pay more for “certain transformative new devices” for inpatients through a […]
Procept BioRobotics touts slew of Aquablation therapy study results
Procept BioRobotics today released results from a slew of studies of its Aquablation therapy provided with its Aquabeam robotic system, touting the device as durable, safe and effective. The AquaBeam system uses a robotically controlled waterjet to ablate prostate tissue without needing heat, the Redwood Shores, Calif.-based company said Results from the trials were presented […]
Hydrocision, Procept BioRobotics ink licensing deal
Hydrocision said today that it inked an exclusive worldwide licensing deal to allow Procept BioRobotics to use its pump cartridge technology for urological applications. Through the agreement, Redwood Shores, Calif.-based Procept BioRobotics will gain the rights to use Boston-based Hydrocision’s pump cartridge technology in its AquaBeam robotic system designed to performed autonomous tissue removal for […]
Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018
Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report. The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other […]
Procept BioRobotics wins UK NICE nod, CMS NTAP approval
Procept BioRobotics said today that it won an Interventional Procedure Guidance recommendation from the UK’s National Institute for Health and Clinical Excellence for is Aquablation therapy as an alternative technique for treating benign prostatic hyperplasia. The AquaBeam system uses a robotically controlled waterjet to ablate prostate tissue without needing heat, the Redwood Shores, Calif.-based company said […]
